|
Volumn 26, Issue 4, 2003, Pages 239-242
|
Port Needles: Do They Need to be Removed as Frequently in Infusional Chemotherapy?
c
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARBOPLATIN;
CISPLATIN;
CYTOSTATIC AGENT;
EPIRUBICIN;
FLUOROURACIL;
GEMCITABINE;
IRINOTECAN;
NAVELBINE;
ANTINEOPLASTIC AGENT;
ADULT;
AGED;
ARTICLE;
ASEPSIS;
CANCER CHEMOTHERAPY;
CATHETER INFECTION;
CENTRAL VENOUS CATHETER;
CONTINUOUS INFUSION;
DRUG DELIVERY SYSTEM;
FEMALE;
HUBER NEEDLE;
HUMAN;
INFLAMMATION;
INFUSION;
INJECTION SITE;
MAJOR CLINICAL STUDY;
MALE;
NEEDLE;
PRIORITY JOURNAL;
PROTRACTED CHEMOTHERAPY;
SIDE EFFECT;
SOLID TUMOR;
THROMBOGENESIS;
CENTRAL VENOUS CATHETERIZATION;
CLINICAL NURSING RESEARCH;
CLINICAL TRIAL;
CROSS INFECTION;
DEVICE REMOVAL;
EQUIPMENT DESIGN;
FEASIBILITY STUDY;
INDWELLING CATHETER;
INSTRUMENTATION;
INTRAVENOUS DRUG ADMINISTRATION;
METHODOLOGY;
MIDDLE AGED;
NURSING;
ONCOLOGY NURSING;
PHLEBITIS;
SKIN CARE;
THROMBOSIS;
TIME;
TURKEY (REPUBLIC);
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS;
CATHETERIZATION, CENTRAL VENOUS;
CATHETERS, INDWELLING;
CLINICAL NURSING RESEARCH;
CROSS INFECTION;
DEVICE REMOVAL;
EQUIPMENT DESIGN;
FEASIBILITY STUDIES;
FEMALE;
HUMANS;
INFLAMMATION;
INFUSIONS, INTRAVENOUS;
MALE;
MIDDLE AGED;
NEEDLES;
ONCOLOGIC NURSING;
PHLEBITIS;
SKIN CARE;
THROMBOSIS;
TIME FACTORS;
TURKEY;
|
EID: 0042736494
PISSN: 15331458
EISSN: None
Source Type: Journal
DOI: 10.1097/00129804-200307000-00009 Document Type: Article |
Times cited : (13)
|
References (5)
|